Blog
RSS FeedPosted by Michael Wonder on 28 Apr 2020
Most Americans believe Trump has failed to make progress lowering drug prices
28 April 2020 - More than one-third of U.S. adults believe that prescription drug prices have increased a lot since ...
Posted by Michael Wonder on 27 Apr 2020
Ousting vaccine chief ‘is going to set us back,’ former FDA head says
26 April 2020 - Scott Gottlieb says Rick Bright’s departure is likely to be counterproductive. ...
Posted by Michael Wonder on 25 Apr 2020
FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems
24 April 2020 - Close supervision is strongly recommended. ...
Posted by Michael Wonder on 25 Apr 2020
CSL's blood payments in US under the microscope
25 April 2020 - CSL has been forced to defend the way it runs its blood plasma collection business in ...
Posted by Michael Wonder on 25 Apr 2020
EU actions to support availability of medicines during COVID-19 pandemic – update #3
24 April 2020 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a virtual ...
Posted by Michael Wonder on 25 Apr 2020
FDA’s Woodcock on authorising the emergency use for hydroxychloroquine: ‘we did the best we could’
24 April 2020 - Over the past few weeks, the FDA has been criticised for some of the steps taken – ...
Posted by Michael Wonder on 23 Apr 2020
Essential work to combat the COVID-19 pandemic to continue during EMA's closure on 27 April and on 1 May 2020
23 April 2020 - EMA has put measures in place to ensure that its activities related to the COVID-19 pandemic ...
Posted by Michael Wonder on 23 Apr 2020
COVID-19: reminder of risk of serious side effects with chloroquine and hydroxychloroquine
23 April 2020 - Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated ...
Posted by Michael Wonder on 22 Apr 2020
Doctor says he was removed from federal post after opposing funding for unproven drugs
22 April 2020 - The former head of the federal office that will be at the forefront of developing a ...
Posted by Michael Wonder on 21 Apr 2020
DOJ clears U.S. drug companies to distribute hydroxychloroquine to coronavirus patients
21 April 2020 - The U.S. Department of Justice on Monday cited "extreme urgency" in clearing U.S. pharmaceutical distributors from ...
Posted by Michael Wonder on 21 Apr 2020
Launch of enhanced monitoring system for availability of medicines used for treating COVID-19
21 April 2020 - EMA, together with the pharmaceutical industry and the EU Member States, has launched its enhanced fast-track ...
Posted by Michael Wonder on 20 Apr 2020
Crisis or not, Alberta must not do an end-run around Health Canada
20 April 2020 - On April 12, in response to a perceived delay in Health Canada’s approval of a Canadian-made ...
Posted by Michael Wonder on 20 Apr 2020
Update to guidance on regulatory expectations in the context of COVID-19 pandemic
20 April 2020 - The European Commission, EMA and the national competent authorities have agreed a series of measures to ...
Posted by Michael Wonder on 20 Apr 2020
EU actions to support availability of medicines during COVID-19 pandemic – update #2
20 April 2020 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events held a virtual ...
Posted by Michael Wonder on 18 Apr 2020
Prescription drug costs are spiralling, but price controls are the wrong solution
19 April 2020 - Congress is considering two plans to reduce high drug prices. ...